Constitutive Expression of HCA₂ in Human Retina and Primary Human Retinal Pigment Epithelial Cells

References

• Davenport AP, Anthony P, Sharman JL, Pawson AJ, Benson HE, Monaghan AE, et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands Pharmacol Rev 2013;65:967–986
   Google Scholar
• Offermanns S. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends Pharmacol Sci 2006;27:384–390
   PubMed Web of Science ®Google Scholar
• Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, et al. (2003) PUMA-G and HM74 are receptors for nicotinic acid and mediate its antilipolytic effect. Nat Med 2003;9:352–355
   PubMed Web of Science ®Google Scholar
• Wise A, Foord SM, Fraser NJ, Barnes AA, Elshourbagy N, Eilert M, et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003;278:9869–9874
   PubMed Web of Science ®Google Scholar
• Carlson LA. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J Intern Med 2005;258:94–114
   PubMed Web of Science ®Google Scholar
• Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, et al. (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 2005;280:26649–26652
   PubMed Web of Science ®Google Scholar
• Maciejewski-Lenoir D, Richman JG, Hakak Y, Gaidarov I, Behan DP, Connolly DT. Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol 2006;126:2637–2646
   PubMed Web of Science ®Google Scholar
• Bermudez Y, Benavente CA, Meyer RG, Coyle WR, Jacobson MK, Jacobson EL. Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. PLoS One 2011;6:e20487
   Google Scholar
• Hanson J, Gille A, Zwykiel S, Lukasova M, Clausen BE, Ahmed K, et al. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. J Clin Invest 2010;120:2910–2919
   PubMed Web of Science ®Google Scholar
• Benyó Z, Gille A, Kero J, Csiky M, Suchánková MC, Nüsing RM, et al. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 2005;115:3634–3640
   PubMed Web of Science ®Google Scholar
• Benyó Z, Gille A, Bennett CL, Clausen BE, Offermanns S. Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. Mol Pharmacol 2006;70:1844–1849
   PubMed Web of Science ®Google Scholar
• Martin PM, Ananth S, Cresci G, Roon P, Smith S, Ganapathy V. Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium. Mol Vis 2009;15:362–372
   Google Scholar
• Rubic T, Trottmann M, Lorenz RL. Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin. Biochem Pharmacol 2004;67:411–419
   PubMed Web of Science ®Google Scholar
• Duncan KG, Hosseini K, Bailey KR, Yang H, Lowe RJ, Matthes MT, et al. Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. Br J Ophthalmol 2009;93:1116–1120
   Google Scholar
• Campochiaro PA, Jerdon JA, Glaser BM. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci 1986;27:1615–1621
   PubMed Web of Science ®Google Scholar
• Alge CS, Priglinger SG, Neubauer AS, Kampik A, Zillig M, Bloemendal H, et al. Retinal pigment epithelium is protected against apoptosis by alphaB-crystallin. Invest Ophthalmol Vis Sci 2002;43:3575–3582
   PubMedGoogle Scholar
• Yu AL, Lorenz RL, Haritoglou C, Kampik A, Welge-Lussen U. Biological effects of native and oxidized low-density lipoproteins in cultured human retinal pigment epithelial cells. Exp Eye Res 2009;88:495–503
   PubMed Web of Science ®Google Scholar
• Leschey KH, Hackett SF, Singer JH, Campochiaro PA. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1990;31:839–846
   PubMed Web of Science ®Google Scholar
• Welge-Lüssen U, May CA, Eichhorn M, Bloemendal H, Lutjen-Drecoll E. αB-crystallin in the trabecular meshwork is inducible by transforming growth factor-β. Invest Ophthalmol Vis Sci 1999;40:2235–2241
   Google Scholar
• Li X, Millar JS, Brownell N, Briand F, Rader DJ. Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes. Biochem Pharmacol 2010;80:1450–1457
   Google Scholar
• Gambhir D, Ananth S, Veeranan-Karmegam R, Elangovan S, Hester S, Jennings E, et al. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy. Invest Ophthalmol Vis Sci 2012;53:2208–2217
   PubMed Web of Science ®Google Scholar
• Wanders D, Judd RL. Future of GPR109A agonists in the treatment of dyslipidaemia. Diabetes Obes Metab 2011;13:685–691
   PubMedGoogle Scholar
• Plaisance EP, Lukasova M, Offermanns S, Zhang Y, Cao G, Judd RL. Niacin stimulates adiponectin secretion through the GPR109A receptor. Am J Physiol Endocrinol Metab 2009;296:549–558
   Web of Science ®Google Scholar
• Costagliola C, Daniele A, dell’Omo R, Romano MR, Aceto F, Agnifili L, et al. Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection. Exp Eye Res 2013;110:50–54
   PubMed Web of Science ®Google Scholar
• Ganapathy V, Ramamoorthy JD, Del Monte MA, Leibach FH, Ramamoorthy S. Cyclic AMP-dependent up-regulation of the taurine transporter in a human retinal pigment epithelial cell line. Curr Eye Res 1995;14:843–850
   PubMed Web of Science ®Google Scholar
• Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986;8:1245–1255
   PubMed Web of Science ®Google Scholar
• Lukasova M, Malaval C, Gille A, Kero J, Offermanns S. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 2011;121:1163–1173
   PubMed Web of Science ®Google Scholar
• Robman L, McNeil J, Dimitrov P, Dowrick A, Tikellis G, Nicolas C, et al. Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) Study. Ophthalmic Epidemiol 2004;11:161–179
   PubMed Web of Science ®Google Scholar
• Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995;142:404–409
   PubMed Web of Science ®Google Scholar
• Guymer RH, Dimitrov PN, Varsamidis M, Lim LL, Baird PN, Vingrys AJ, et al. Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS). Clin Interv Aging 2008;3:581–593
   PubMed Web of Science ®Google Scholar
• Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995;113:743–748
   PubMed Web of Science ®Google Scholar
• Tan JS, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2007;114:1143–1150
   PubMed Web of Science ®Google Scholar
• Bora PS, Kaliappan S, Lyzogubov VV, Tytarenko RG, Thotakura S, Viswanathan T, Bora NS. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett 2007;581:1977–1982
   PubMed Web of Science ®Google Scholar
• Gass JD. Nicotinic acid maculopathy. 1973. Retina 2003;23:500–510
   Google Scholar
• Millay RH, Klein ML, Illingworth DR. Niacin maculopathy. Ophthalmology 1988;95:930–936
   PubMed Web of Science ®Google Scholar
• Jampol LM. Niacin maculopathy. Ophthalmology 1988;95:1704–1705
   PubMedGoogle Scholar
• Tachikawa M, Murakami K, Martin PM, Hosoya K, Ganapathy V. Retinal transfer of nicotinate by H+ -monocarboxylate transporter at the inner blood-retinal barrier. Microvasc Res 2011;82:385–390
   PubMed Web of Science ®Google Scholar